Target intelligence / Profile preview

Cation-transporting ATPase 4 (PfATP4) (PfATP4)

Target
PfATP4
Molecular classification
Transporter, P-type ATPase, Ion pump, Enzyme
01

Overview

Cation-transporting ATPase 4 (PfATP4) is an essential P-type ATPase located on the plasma membrane of the malaria parasite Plasmodium falciparum. It functions as a sodium-efflux pump, maintaining a low intracellular sodium concentration against the high sodium environment of the host's blood, which is vital for the parasite's osmotic stability and pH regulation. PfATP4 has emerged as a high-priority therapeutic target because it is inhibited by several chemically diverse classes of next-generation antimalarial compounds, including spiroindolones and aminobenzimidazoles. Inhibition of PfATP4 leads to a rapid and lethal influx of sodium ions into the parasite, resulting in cellular swelling and lysis. Because PfATP4 is structurally distinct from human ion pumps, it offers a high degree of selectivity and remains effective against parasite strains resistant to current frontline treatments like chloroquine and artemisinin.

Other names
PfATP4P-type ATPase 4Sodium-transporting ATPase 4ENA-like ATPasePlasmodium falciparum cation-transporting ATPase 4
02

Mechanism of action

Inhibition of PfATP4-mediated sodium efflux, leading to a rapid increase in intracellular sodium concentration, osmotic stress, and parasite death.

03

Biological functions

Sodium homeostasisOsmotic regulationpH regulationIon transportCell volume control
04

Disease associations

Malaria
05

Safety considerations

Development of drug resistance through pfatp4 gene mutationsSelectivity over human P-type ATPases (e.g., Na+/K+ ATPase)Potential for cross-resistance among different PfATP4 inhibitor classes
06

Interacting drugs

Cipargamin (KAE609)

4 more in the full profile.

07

Biomarkers

pfatp4 gene mutations (e.g., G358S, L350H, P412L, T418N)Parasite clearance rateIntracellular sodium concentration ([Na+]i)

Beyond the preview

Go deeper on Cation-transporting ATPase 4 (PfATP4) (PfATP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cation-transporting ATPase 4 (PfATP4) (PfATP4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call